Xing-li Zou
Nanchong, 637000, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Analysis of Risk Factors for Early Relapse/Progression in Patients with Multiple Myeloma and Development of a Nomogram Prediction Model
Journal: Zhongguo shi yan xue ye xue za zhi
Published: January 08, 2026
Real-World Study of 21-Day Venetoclax Plus Azacitidine Regimen in the Treatment of Newly Diagnosed Unfit-Acute Myeloid Leukemia
Journal: Zhongguo shi yan xue ye xue za zhi
Published: November 14, 2025
Efficacy and Safety of Flumatinib and Imatinib as First-line Treatments for Newly-diagnosed Chronic Myeloid Leukemia in Chronic Phase: A Real-world Study
Journal: Zhongguo shi yan xue ye xue za zhi
Published: January 01, 2025
Comparison of the Prognostic Value of C-Reactive Protein to Albumin Ratio and Glasgow Prognostic Score in Patients with Diffuse Large B-Cell Lymphoma
Journal: Zhongguo shi yan xue ye xue za zhi
Published: June 27, 2024
Prognostic Value of Pre-treatment Albumin/Fibrinogen Ratio in Patients with Diffuse Large B-cell Lymphoma
Journal: Zhongguo shi yan xue ye xue za zhi
Published: June 25, 2023
Predictive Value of Pre-treatment Serum Uric Acid Level for Prognosis in Newly Diagnosed Patients with Multiple Myeloma
Journal: Zhongguo shi yan xue ye xue za zhi
Published: August 07, 2021
Short-Term Efficacy and Safety Profile of Generic Bortezomib in the Treatment of Multiple Myeloma
Journal: Zhongguo shi yan xue ye xue za zhi
Published: February 08, 2021
Effect of High Dose Vitamin C on Proliferation and Apoptosis of Acute Myeloid Leukemia Cells
Journal: Zhongguo shi yan xue ye xue za zhi
Published: June 20, 2020
FLT3 mutation in acute promyelocytic leukemia patients with extramedullary relapse
Journal: Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition
Published: October 08, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026